MedTrace Logo

Methotrexate Adherence in Rheumatoid Arthritis Patients

NCT05535686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-09-10

No results posted yet for this study

Summary

This study was conducted for assessment of adherence of Rheumatoid Arthritis patients to Methotrexate as a gold standard drug for treatment of R.A. Moreover, evaluating the effect of drug adherence to patient quality of life.

Conditions

Interventions

OTHER

Rheumatoid Arthritis

Rheumatoid Arthritis Disease (R.A)

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2022-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05535686 on ClinicalTrials.gov